Clinical study of renal impairment in patients with propylthiouracil-induced small-vessel vasculitis and patients with primary ANCA-associated small-vessel vasculitis
Authors:
Open Access
- 15 April 2013
- journal article
- Published by Spandidos Publications in Experimental and Therapeutic Medicine
- Vol. 5 (6) , 1619-1622
Abstract
The aim of this study was to compare renal impairment in patients with propylthiouracil (PTU)-induced small-vessel vasculitis and patients with primary anti-neutrophil cytoplasmic antibody (ANCA)-induced small-vessel vasculitis. The study compared the pathology and clinical conditions of 10 patients with PTU-associated small-vessel vasculitis and 18 patients with primary ANCA-associated small-vessel vasculitis. All patients showed manifestations of renal impairment. Compared with the primary ANCA-induced small-vessel vasculitis, patients with PTU-induced small-vessel vasculitis were mostly female (P<0.05) and deleloped the disease at a younger age (P<0.05). They had a higher positive rate of perinuclear anti-neutrophil cytoplasmic antibody (p-ANCA; P<0.05), lower 24 h proteinuria content, lower serum creatinine (P<0.05) and milder histopathological lesions (P<0.05). A number of them had gross hematuria (P<0.05). They rarely used hormone and cytotoxic drugs (P<0.05) during treatment and had a better prognosis (P<0.05). In conclusion, PTU-induced small-vessel vasculitis has a milder pathology and clinical manifestations with a better prognosis.Keywords
This publication has 22 references indexed in Scilit:
- Drug-induced vasculitis: a clinical and pathological review.2012
- Atualização do tratamento das vasculites associadas a anticorpo anticitoplasma de neutrófilosJornal Brasileiro de Pneumologia, 2011
- Churg-Strauss Syndrome: An UpdateCurrent Rheumatology Reports, 2011
- Churg-strauss syndromeIndian Journal of Dermatology, 2011
- ANCA-associated vasculitides: advances in pathophysiology and treatment.2010
- Churg–Strauss syndrome: evidence for disease subtypes?Current Opinion in Rheumatology, 2010
- Treatment of Antineutrophil Cytoplasmic Antibody–Associated VasculitisJAMA, 2007
- Antineutrophil cytoplasmic antibodiesThe Lancet, 2006
- The safety and efficacy of antithyroid drugsExpert Opinion on Drug Safety, 2005
- Antithyroid DrugsNew England Journal of Medicine, 2005